- Home
- EYEN vs IBG Comparison
EYEN vs IBG Comparison
Compare EYEN & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYEN
- IBG
- Stock Information
- Founded
- EYEN 2014
- IBG 2018
- Country
- EYEN United States
- IBG Australia
- Employees
- EYEN N/A
- IBG N/A
- Industry
- EYEN Biotechnology: Pharmaceutical Preparations
- IBG Beverages (Production/Distribution)
- Sector
- EYEN Health Care
- IBG Consumer Staples
- Exchange
- EYEN Nasdaq
- IBG Nasdaq
- Market Cap
- EYEN 3.7M
- IBG 4.1M
- IPO Year
- EYEN 2018
- IBG 2024
- Fundamental
- Price
- EYEN $1.12
- IBG $1.05
- Analyst Decision
- EYEN Hold
- IBG Strong Buy
- Analyst Count
- EYEN 4
- IBG 1
- Target Price
- EYEN $2.00
- IBG N/A
- AVG Volume (30 Days)
- EYEN 495.7K
- IBG 11.2M
- Earning Date
- EYEN 05-14-2025
- IBG 05-15-2025
- Dividend Yield
- EYEN N/A
- IBG N/A
- EPS Growth
- EYEN N/A
- IBG N/A
- EPS
- EYEN N/A
- IBG N/A
- Revenue
- EYEN $31,832.00
- IBG $3,147,763.00
- Revenue This Year
- EYEN $23,413.60
- IBG N/A
- Revenue Next Year
- EYEN $400.98
- IBG N/A
- P/E Ratio
- EYEN N/A
- IBG N/A
- Revenue Growth
- EYEN 2557.09
- IBG N/A
- 52 Week Low
- EYEN $1.06
- IBG $0.44
- 52 Week High
- EYEN $124.80
- IBG $3.35
- Technical
- Relative Strength Index (RSI)
- EYEN 27.91
- IBG N/A
- Support Level
- EYEN $1.06
- IBG N/A
- Resistance Level
- EYEN $1.19
- IBG N/A
- Average True Range (ATR)
- EYEN 0.10
- IBG 0.00
- MACD
- EYEN 0.05
- IBG 0.00
- Stochastic Oscillator
- EYEN 9.05
- IBG 0.00
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter and retailer of a growing beverage portfolio of 60 formulations across 13 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands.